Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-022897

Chairman and CEO bought 13,200 shares at $1.21 ($15,972)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-03-31 Purchase +13,200 $1.21 $15,972 10,531,243 D
Open-market purchases · 13,200 sh · avg $1.21 · $15,972
Loading xslF345X03/doc4.xml…